Blood Products Flashcards

1
Q

Risks with blood transfusions

A

Transfusion reactions - quite common even in appropriately cross-matched blood

Blood products are scarce and should therefore only be used when necessary.

Blood group incompatibility is a rare but life-threatening complication. Blood products therefore need to be appropriately cross-matched and checked to avoid severe consequences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NICE guidelines on indication of blood transfusion.

A

Hb threshold of 70 g/L for those who need RBC transfusions.
This is without any major haemorrhage or ACS.

Hb conc. of 70-90 g/L after transfusion is the target.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does RhD+ and RhD- refer to?

A

The presence or absence respectively of Rhesus D surface antigens on the red bloods cells.

Approx 85% of the population is RhD+

RhD- patient will make RhD antibody if they are given RhD+ blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain haemolytic disease of the newborn.

A

A woman is born with RhD- blood. Her partner is RhD+ and she becomes pregnant with a fetus that is also RhD+. During childbirth, she comes into contact with the foetal (Rh+ve) blood and develops antibodies to it.

She later becomes pregnant with a second child that is also Rh +ve.

The woman’s anti-D antibodies cross the placenta during this pregnancy and enter the foetal circulation, which contains RhD+ blood, and bind to the foetus’ RhD antigens on its RBC surface membranes.

This causes the foetal immune system to attack and destroy its own RBCs, leading to foetal anaemia. This is termed haemolytic disease of the newborn (HDN).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is ABO blood groups?

A

Presence of A and/or B antigens on the surface of red blood cells.

The ABO group is important for all individual undergoing a potential blood transfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain how ABO can give blood.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain G&S

A

Determines the patient’s blood group (ABO and RhD) and screens the blood for any atypical antibodies.

The process takes around 40 minutes and no blood is issued. A G&S is recommended if blood loss is not anticipated, but blood may be required should there be greater blood loss than expected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain crossmatch

A

Involves physically mixing the patient’s blood with the donor’s blood, in order to see if any immune reaction takes places. If it does not, the donor blood is issued and can be transfused in to the patient.

This process also takes ~40 minutes, in addition to the 40 minutes required to G&S the blood (which must be done first). A X-match is done if blood loss is anticipated, but the surgeon will usually inform you of this.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is CMV-negative blood products?

A

CMV is a common congenital infection that may lead to sensorineural deafness and cerebral palsy.

Consequently CMV-negative blood should be given to women during pregnancy, intra-uterine transfusions and to neonates up to 28 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are irradiated blood products?

A

Blood that is required to reduce the risk of graft-versus-host-disease in at risk populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who should be given irradiated blood products.

A

Those receiving blood from first or second-degree family members.

Patients with Hodgkin’s Lymphoma

Recent haematopoietic stem cell (HSC) transpants

After Anti-thymocyte globulin (ATG) or Alemtuzumab therapy

Those receiving purine analogues as chemotherapy

Intra-uterine transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

If a patient requires more than one unit of blood, how should this be prescribed?

A

Individually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should observations be carried out when giving blood.

A

Before transfusion starts

15-20 minutes after it has started

At 1 hour after

At completion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What cannulas should be used when giving blood products?

A

Green 18G or Grey 16G cannula

This is because small ones can cause haemolysis by shearing forces.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of blood products

A

Packed Red Cells

Platelets

Fresh Frozen Plasma

Cryoprecipitate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain Packed Red cells

A

More or less just packed red cells

17
Q

Indications of packed red cells

A

Acute blood loss

Chronic anaemia where the HB <70g/L or <100 g/L with cardiovascular disease or symptomatic anaemia.

18
Q

Duration of which Packed red cells are administered.

A

2-4 hours.

Must be completed within 4 hours of coming out of storage

19
Q

How much will 1 unit of blood increase the patient’s Hb

A

Around 10g/L

20
Q

Why does a new G&S need to be sent before giving a second transfusion?

A

Because the patient may produce autoantibodies to donor surface antigens (other than ABO and RhD)

21
Q

Major constituent of platelet transfusion

A

Platelets

22
Q

Indications of platelets transfusion

A

Haemorrhagic shock in a trauma patient

Profound thrombocytopenia <20 x10^9/L where normal range is 150-400.

Bleeding with thrombocytopenia

Pre-op platelet level <50 x 10^9/L

23
Q

Duration of administration of platelets

A

30 minutes

24
Q

How much should one platelet transfusion raise platelets by?

A

20-40 x10^9/L

25
Q

Major constituent of fresh frozen plasma FFP

A

Clotting factors

26
Q

Indications of FFP

A

DIC

Any haemorrhage secondary to liver disease

All massive haemorrhages commonly given after 2nd unit of packed red cells.

27
Q

Duration of administration of FFP

A

30 minutes

28
Q

Major constituents cryoprecipitate.

A

Fibrinogen

vWF

Facto VII

Fibronectin

29
Q

Indications on cryoprecipitate

A

DIC with fibrinogen <1g/L

vWF disease

Massive haemorrhage

30
Q

Duration of administration of cryoprecipitate

A

Stat